Read more about drug-induced liver injury (DILI), hepatotoxicity, and emerging exploratory biomarkers for drug safety studies.
DILI/Hepatotoxicity
Cytokeratin 18/Keratin 18 (CK18/K18)
| Product | Method / Application | Packaging | Use ? | Catalog # |
|---|---|---|---|---|
M30 Apoptosense® CK18 Kit |
ELISA | Kit/96 tests | RUO | P10011 |
M65® ELISA CK18 Kit |
ELISA | Kit/96 tests | RUO | P10020 |
M65 EpiDeath® CK18 Kit |
ELISA | Kit/96 tests | RUO | P10040 |
M30 CytoDeath™ CK18 Kit |
ELISA | Kit/96 tests | RUO | P10900 |
Collagen
Osteopontin (OPN)
| Product | Method / Application | Packaging | Use ? | Catalog # |
|---|---|---|---|---|
Osteopontin (Human) |
ELISA | Kit/96 tests | RUO | DPG27158 |
Osteopontin N-half (Human) |
ELISA | Kit/96 tests | RUO | DPG27258 |
Alpha GST (aGST)
| Product | Method / Application | Packaging | Use ? | Catalog # |
|---|---|---|---|---|
TECO® Alpha GST EIA |
ELISA | Kit/96 tests | RUO | TE1056 |
Fatty Acid Binding Protein (FABP)
| Product | Method / Application | Packaging | Use ? | Catalog # |
|---|---|---|---|---|
DiaPharma L-FABP (FABP1) ELISA |
ELISA | Kit/96 tests | RUO | DPGLFABP |